Effect of chitosan-coated alginate microspheres on the permeability of Caco-2 cell monolayers

Drug Development and Industrial Pharmacy

Volumn 32, Issue 9, 2006, Pages 1079-1088

  Silva, Catarina M ^a   Veiga, Francisco ^a   Ribeiro, António J ^b   Zerrouk, Naïma ^c   Arnaud, Philippe ^d  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY INSTITUTE OF HEALTH SCIENCES IUCS   (Portugal)

^c UNIV PARIS SUD   (France)

^d UNIVERSITÉ DE ROUEN   (France)

Author keywords

Alginate; Caco 2; Chitosan; Microspheres; Paracellular transport

Indexed keywords

ALGINIC ACID; CALCIUM CARBONATE; CHITOSAN; LACTATE DEHYDROGENASE; LUCIFER YELLOW; MICROSPHERE; NEUTRAL RED; SETACARB; SORBITAN OLEATE;

ARTICLE; CELL DAMAGE; CELL STRAIN CACO 2; CELL TRANSPORT; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DRUG BIOAVAILABILITY; DRUG COATING; DRUG PENETRATION; ELECTRIC RESISTANCE; EMULSION; ENZYME RELEASE; EVALUATION; GELATION; HUMAN; HUMAN CELL; HYDROPHILICITY; INTESTINE EPITHELIUM;

ALGINATES; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CELL MEMBRANE PERMEABILITY; CHITOSAN; DRUG CARRIERS; ELECTRIC CONDUCTIVITY; FLUORESCENT DYES; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; ISOQUINOLINES; MICROSPHERES; PARTICLE SIZE; SOLUTIONS; TECHNOLOGY, PHARMACEUTICAL;

EID: 33749477775     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040600735020     Document Type: Article

References (40)

1. Albarghouthi, M., Fara, D. A., Saleem, M., El-Thaher, T., Matalka, K., & Badwan, A. (2000). Immobilization of antibodies on alginatechitosan beads. Int. J. Pharm., 206(1-2), 23-34.
2. Artursson, P. (1993). Cell cultures as models for intestinal peptide transport. STP Pharma. Sci., 3(1), 5-10.
3. Artursson, P., Lindmark, T., Davis, S. S., & Illum, L. (1994). Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm. Res. 11(9), 1358-1361.
4. Aspden, T. J., Illum, L., & Skaugrud, O. (1996). Chitosan as a nasal delivery system: evaluation of insulin absorption enhancement and effect on nasal membrane integrity using rat models. Eur. J. Pharm. Sci., 4, 23-31.
5. Aspden, T. J., Mason, J. D. T., Jones, N. S., Lowe, J., Skaugrud, O., & Illum, L. (1997). Chitosan as a nasal delivery system: the effect of chitosan solutions on "in vitro" and "in vivo" mucociliary transport rates in human turbinates and volunteers. J. Pharm. Sci., 86(4), 509-513.
6. Babich, H., & Bohrenfreund, E. (1990). Application of the neutral red cytotoxicity assay to "in vitro" toxicology. ATLA., 18, 129-144.
7. Chickering, D. E., Jacob, J. S., Desai, T. A., Harrison, M., Harris, W. P., Morrell, C. N., Chaturvedi, P., & Mathiowitz, E. (1997). Bioadhesive microspheres: III. "In vivo" transit and bioavailability study of drug-loaded alginate and poly(fumaric-co-sebacic anhydride) microspheres. J. Control. Rel., 48(Sep 22), 35-46.
8. Daugherty, A. L., & Mrsny, R. (1999). Transcellular uptake mechanisms of the intestinal epithelial barrier. Part one. PSTT., 2(4), 144-151.
9. Decker, T., & Lohmann-Matthes, M. L. (1988). A quick and simple method for the quantification of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J. Immunol. Methods., 115(1), 61-69.
10. DeGroot, A. R., & Neufeld, R. J. (2001). Encapsulation of urease in alginate beads and protection from a-chymotrypsin with chitosan membranes. Enz. Microbial. Technol., 29, 321-327.
11. Dodane, V., Khan, M. A., & Merwin, J. R. (1999). Effect of chitosan on epithelial permeability and structure. Int. J. Pharm., 182, 21-32.
12. Fautz, R., Husein, B., & Hechenberger, C. (1991). Application of the neutral red assay (NR assay) to monolayer cultures of primary hepatocytes: rapid colorimetric viability determination for the unscheduled DNA synthesis test (UDS). Mutat. Res., 253(2), 173-179.
13. Gres, M. C., Julian, B., Bourrié, M., Meunier, V., Roques, B., Berger, M., Boulenc, X., Berger, Y., & Fabre, G. (1998). Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line. Pharm. Res., 15(5), 726-733.
14. Hidalgo, I. J., Raub, T. J., & Borchardt, R. T. (1989). Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology, 96, 736-749.
15. Huang, M., Khor, E., & Lim, L. Y. (2004). Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation. Pharm. Res., 21(2), 344-353.
16. Illum, L., Farraj, N. F., & Davis, S. S. (1994). Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res., 11(8), 1186-1189.
17. Klinkenberg, G., Lystad, K. Q., Levine, T. D. W., & Dyrset, N. (2001). Cell release from alginate immobilized Lactococcus lactis ssp. lactis in chitosan and alginate coated beads. J. Dairy Sci., 84(5), 1118-1127.
18. Konishi, Y. (2003). Modulations of food-derived substances on intestinal permeability in Caco-2 cell monolayers. Biosci. Biotech. Biochem., 67(10), 2297-2299.
19. Kotze, A. F., Leeuw, B. J., Lueßen, H. L., de Boer, A. G., Verhoef, J. C., & Junginger, H. E. (1997). Chitosans for enhanced delivery of therapeutic peptides across intestinal epithelia: "in vitro" evaluation in Caco-2 cell monolayers. Int. J. Pharm., 159, 243-253.
20. Lehr, C.-M., Bouwstra, J. A., Schacht, E. H., & Junginger, H. E. (1992). "In vitro" valuation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm., 78, 43-48.
21. Lueßen, H. L., Leeuw, B. J., Langemeyer, W. E., de Boer, A. G., Verhoef, J. C., & Junginger, H. E. (1996). Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin "in vivo." Pharm. Res., 13(11), 1668-1672.
22. Lueßen, H. L., Lehr, C.-M., Rentel, C.-O., Noach, A. B. J., de Boer, A. G., Verhoef, J. C., & Junginger, H. E. (1994). Bioadhesive polymers for the peroral delivery of peptide drugs. J. Control. Rel., 29, 329-338.
23. Lueßen, H. L., Rentel, C.-O., Kotze, A. F., Lehr, C.-M., de Boer, A. G., Verhoef, J. C., & Junginger, H. E. (1997). Mucoadhesive polymers in peroral peptide drug delivery. IV. Polycarbophil and chitosan are potent enhancers of peptide transport across intestinal mucosae "in vitro". J. Control. Rel., 45, 15-23.
24. Onal, S., & Zihnioglu, F. (2002). Encapsulation of insulin in chitosan-coated alginate beads: Oral therapeutic peptide delivery. Artif. Cells Blood Substit. Immobil. Biotechnol., 30(3), 229-237.
25. Pinto, M., Robine-Leon, S., Appay, M. D., Kedinger, M., Triadou, N., Dussaulx, E., Lacroix, B., Simon-Assmann, P., Haffen, K., Fogh, J., & Zweibaum, A. (1983). Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol. Cell., 47, 323-330.
26. Poncelet, D., Lencki, R., Beaulieu, C., Halle, J. P., Neufeld, R. J., & Fournier, A. (1992). Production of alginate beads by emulsification/ internal gelation. I. Methodology. Appl. Microbiol. Biotechnol., 38, 39-45.
27. Quong, D., Neufeld, R. J., Skjak-Braek, G., & Poncelet, D. (1998). External versus internal source of calcium during the gelation of alginate beads for DNA encapsulation. Biotechnol. Bioeng., 57(4), 438-446.
28. Quong, D., Yeo, J. N., & Neufeld, R. J. (1999). Stability of chitosan and poly-L-lysine membranes coating DNA-alginate beads when exposed to hydrolytic enzymes. J. Microencapsul., 16(1), 73-82.
29. Ribeiro, A. J., Silva, C., Ferreira, D., & Veiga, F. (2005). Chitosan-reinforced alginate microspheres obtained through the emulsification/internal gelation technique. Eur. J. Pharm. Sci., 25, 31-40.
30. Schipper, N. G. M., Olsson, S., Hoogstraate, J. A., de Boer, A. G., Varum, K. M., & Artursson, P. (1997). Chitosans as absorption enhancers for poorly absorbable drugs 2: Mechanism of absorption enhancement. Pharm. Res., 14(7), 923-929.
31. Schipper, N. G. M., Varum, K. M., & Artursson, P. (1996). Chitosans as absorption enhancers for poorly absorbable drugs. 1: Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (caco-2) cells. Pharm. Res., 13(11), 1686-1692.
32. Schipper, N. G. M., Varum, K. M., Stenberg, P., Ocklind, G., Lennernas, H., & Artursson, P. (1999). Chitosans as absorption enhancers of poorly absorbable drugs 3: Influence of mucus on absorption enhancement. Eur. J. Pharm. Sci., 8, 335-343.
33. Senel, S., Kremer, M. J., Kas, S., Wertz, P. W., Hincal, A. A., & Squier, C. A. (2000). Enhancing effect of chitosan on peptide drug delivery across buccal mucosa. Biomaterials., 21(20), 2067-2071.
34. Smith, J., Wood, E., & Dornish, M. (2004). Effect of chitosan on epithelial cell tight junctions. Pharm. Res., 21(1), 43-49.
35. Smith, J. M., Dornish, M., & Wood, E. J. (2005). Involvement of protein kinase C in chitosan glutamate-mediated tight junction disruption. Biomaterials., 26, 3269-3276.
36. Tengamnuay, P., Sahamethapat, A., Sailasuta, A., & Mitra, A. K. (2000). Chitosans as nasal absorption enhancers of peptides: comparison between free amine chitosans and soluble salts. Int. J. Pharm., 197, 53-67.
37. Thanou, M., Verhoef, J. C., & Junginger, H. E. (2001). Chitosan and its derivatives as intestinal absorption enhancers. Adv. Drug Deliv. Rev., 50, S91-S101.
38. Tsukazaki, M., Satsu, H., Mori, A., Sugita-Konishi, Y., & Shimizu, M. (2004). Effects of tributyltin on barrier functions in human intestinal Caco-2 cells. Biochem. Biophys. Res. Commun., 315, 991-997.
39. Yamashita, S., Furubayashi, T., Kataoka, M., Sakane, T., Sezaki, H., & Tokuda, H. (2000). Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. Eur. J. Pharm. Sci., 10, 195-204.
40. Zhou, X. H. (1994). Overcoming enzymatic and absorption barriers to nonparenterally administered protein and peptide drugs. J. Control. Rel., 29, 239-252